Chuck Akre acquired 2.24 Million SOPHiA Genetics SA shares worth $6.69 Million. That's 0.06% of their equity portfolio (15th largest holding). The investor owns 3.11% of the outstanding SOPHiA Genetics SA stock. The investor's estimated purchase price is $10.6 Million, resulting in a loss of 37%.